Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning.

Polano M, Chierici M, Dal Bo M, Gentilini D, Di Cintio F, Baboci L, Gibbs DL, Furlanello C, Toffoli G.

Cancers (Basel). 2019 Oct 15;11(10). pii: E1562. doi: 10.3390/cancers11101562.

2.

Evaluating reproducibility of AI algorithms in digital pathology with DAPPER.

Bizzego A, Bussola N, Chierici M, Maggio V, Francescatto M, Cima L, Cristoforetti M, Jurman G, Furlanello C.

PLoS Comput Biol. 2019 Mar 27;15(3):e1006269. doi: 10.1371/journal.pcbi.1006269. eCollection 2019 Mar.

3.

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.

Boldrini R, De Pasquale MD, Melaiu O, Chierici M, Jurman G, Benedetti MC, Salfi NC, Castellano A, Collini P, Furlanello C, Pistoia V, Cifaldi L, Terenziani M, Fruci D.

Oncoimmunology. 2018 Dec 13;8(2):e1542245. doi: 10.1080/2162402X.2018.1542245. eCollection 2019.

4.

Machine learning models for predicting endocrine disruption potential of environmental chemicals.

Chierici M, Giulini M, Bussola N, Jurman G, Furlanello C.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2018;36(4):237-251. doi: 10.1080/10590501.2018.1537155. Epub 2019 Jan 10.

PMID:
30628533
5.

Stability in GRN Inference.

Jurman G, Filosi M, Visintainer R, Riccadonna S, Furlanello C.

Methods Mol Biol. 2019;1883:323-346. doi: 10.1007/978-1-4939-8882-2_14.

PMID:
30547407
6.

Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.

Maggio V, Chierici M, Jurman G, Furlanello C.

PLoS One. 2018 Dec 7;13(12):e0208924. doi: 10.1371/journal.pone.0208924. eCollection 2018.

7.

Novelty Detection using Deep Normative Modeling for IMU-Based Abnormal Movement Monitoring in Parkinson's Disease and Autism Spectrum Disorders.

Mohammadian Rad N, van Laarhoven T, Furlanello C, Marchiori E.

Sensors (Basel). 2018 Oct 19;18(10). pii: E3533. doi: 10.3390/s18103533.

8.

Multi-omics integration for neuroblastoma clinical endpoint prediction.

Francescatto M, Chierici M, Rezvan Dezfooli S, Zandonà A, Jurman G, Furlanello C.

Biol Direct. 2018 Apr 3;13(1):5. doi: 10.1186/s13062-018-0207-8.

9.

Phylogenetic convolutional neural networks in metagenomics.

Fioravanti D, Giarratano Y, Maggio V, Agostinelli C, Chierici M, Jurman G, Furlanello C.

BMC Bioinformatics. 2018 Mar 8;19(Suppl 2):49. doi: 10.1186/s12859-018-2033-5.

10.

Physiological and self-report responses of parents of children with autism spectrum disorder to children crying.

Ozturk Y, Bizzego A, Esposito G, Furlanello C, Venuti P.

Res Dev Disabil. 2018 Feb;73:31-39. doi: 10.1016/j.ridd.2017.12.004. Epub 2017 Dec 12.

PMID:
29245046
11.

The international MAQC Society launches to enhance reproducibility of high-throughput technologies.

Shi L, Kusko R, Wolfinger RD, Haibe-Kains B, Fischer M, Sansone SA, Mason CE, Furlanello C, Jones WD, Ning B, Tong W.

Nat Biotechnol. 2017 Dec 8;35(12):1127-1128. doi: 10.1038/nbt.4029. No abstract available.

PMID:
29220036
12.

Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.

Gnani D, Romito I, Artuso S, Chierici M, De Stefanis C, Panera N, Crudele A, Ceccarelli S, Carcarino E, D'Oria V, Porru M, Giorda E, Ferrari K, Miele L, Villa E, Balsano C, Pasini D, Furlanello C, Locatelli F, Nobili V, Rota R, Leonetti C, Alisi A.

Cell Death Differ. 2017 May;24(5):889-902. doi: 10.1038/cdd.2017.34. Epub 2017 Mar 24.

13.

PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.

Melaiu O, Mina M, Chierici M, Boldrini R, Jurman G, Romania P, D'Alicandro V, Benedetti MC, Castellano A, Liu T, Furlanello C, Locatelli F, Fruci D.

Clin Cancer Res. 2017 Aug 1;23(15):4462-4472. doi: 10.1158/1078-0432.CCR-16-2601. Epub 2017 Mar 7.

14.

DTW-MIC Coexpression Networks from Time-Course Data.

Riccadonna S, Jurman G, Visintainer R, Filosi M, Furlanello C.

PLoS One. 2016 Mar 31;11(3):e0152648. doi: 10.1371/journal.pone.0152648. eCollection 2016.

15.

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.

Del Chierico F, Nobili V, Vernocchi P, Russo A, De Stefanis C, Gnani D, Furlanello C, Zandonà A, Paci P, Capuani G, Dallapiccola B, Miccheli A, Alisi A, Putignani L.

Hepatology. 2017 Feb;65(2):451-464. doi: 10.1002/hep.28572. Epub 2016 Jun 2.

PMID:
27028797
16.

The Constrained Maximal Expression Level Owing to Haploidy Shapes Gene Content on the Mammalian X Chromosome.

Hurst LD, Ghanbarian AT, Forrest AR; FANTOM consortium, Huminiecki L.

PLoS Biol. 2015 Dec 18;13(12):e1002315. doi: 10.1371/journal.pbio.1002315. eCollection 2015 Dec.

17.

Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.

Carbajo D, Magi S, Itoh M, Kawaji H, Lassmann T, Arner E, Forrest AR, Carninci P, Hayashizaki Y, Daub CO; FANTOM consortium, Okada-Hatakeyama M, Mar JC.

PLoS One. 2015 Dec 14;10(12):e0144176. doi: 10.1371/journal.pone.0144176. eCollection 2015.

18.

Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.

Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group.

Inflamm Bowel Dis. 2016 Feb;22(2):487-504. doi: 10.1097/MIB.0000000000000602. Review.

PMID:
26588090
19.

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.

Ceccarelli S, Panera N, Mina M, Gnani D, De Stefanis C, Crudele A, Rychlicki C, Petrini S, Bruscalupi G, Agostinelli L, Stronati L, Cucchiara S, Musso G, Furlanello C, Svegliati-Baroni G, Nobili V, Alisi A.

Oncotarget. 2015 Dec 8;6(39):41434-52. doi: 10.18632/oncotarget.5163.

20.

Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma.

Mina M, Boldrini R, Citti A, Romania P, D'Alicandro V, De Ioris M, Castellano A, Furlanello C, Locatelli F, Fruci D.

Oncoimmunology. 2015 Apr 2;4(9):e1019981. eCollection 2015 Sep.

Supplemental Content

Loading ...
Support Center